[Bronchopulmonary dysplasia in the newborn: physiopathology, treatment and prevention]

Arch Pediatr. 2015 May;22(5 Suppl 1):103-4. doi: 10.1016/S0929-693X(15)30052-X.
[Article in French]
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bronchopulmonary Dysplasia / physiopathology*
  • Bronchopulmonary Dysplasia / therapy*
  • Caffeine / therapeutic use
  • Central Nervous System Stimulants / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Infant, Newborn
  • Oxygen Inhalation Therapy
  • Pregnancy
  • Prenatal Care
  • Pulmonary Surfactants / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Central Nervous System Stimulants
  • Glucocorticoids
  • Pulmonary Surfactants
  • Caffeine